Investigating the effect of combined mouthwash of chlorhexidine, benzydamine, nanosilver and antibiotics in perichronitis patients
Phase 3
Recruiting
- Conditions
- pericoronitis.
- Registration Number
- IRCT20230104057046N1
- Lead Sponsor
- Gorgan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 58
Inclusion Criteria
Acute perichronitis
The need to be available during the research process
Having informed consent
Exclusion Criteria
presence of chronic systemic disease (diabetes, kidney disease)
receiving systemic or local antibiotic therapy in the last 3 months
chronic perichronitis
symptoms of severe perichronitis such as fever (<38.3°C) and facial swelling
Periodontal disease in the area of ??perichronitis
Smoking
Alcohol consumption
Pregnancy and breastfeeding
Allergy to amoxicillin or non-steroidal anti-inflammatory drugs
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: Examining the amount of pain before using mouthwash and on days 1, 2, 3, 4, 5, 6 and 7 after using combined mouthwash compared to chlorhexidine mouthwash in perichronitis patients. Method of measurement: The amount of pain will be measured according to the standard VAS scale on a 100 mm chart.;Maximum mouth opening of pericroniitis patients. Timepoint: Investigating the amount of maximum mouth opening before using mouthwash and on days 1, 2, 3, 4, 5, 6 and 7 after using combined mouthwash compared to chlorhexidine mouthwash in perichronitis patients. Method of measurement: The maximum amount of mouth opening by a graduated ruler.
- Secondary Outcome Measures
Name Time Method